
Athanasia Vlachou
General Hospital George Papanikolaou, GreeceTitle: Successful surgical treatment of Fabry disease with aortic valve stenosis. A Case Report.
Abstract
Cardiac involvement is
common in Fabry disease. Usually it includes cardiac hypertrophy, decreased
left ventricle systolic function, ischaemia and coronary events, arrhythmias
and valvular abnormalities. A 50 year old male with Fabry disease was admitted
to our department for aortic valve replacement. He was treated with recombinant
a-galactosidase enzyme replacement for 14 years. Cardiac workup revealed severe
left ventricular hypertrophy, severe aortic stenosis with Peak gradient
120mmHg, moderate aortic regurgitation and moderate mitral stenosis. He
underwent mechanical valvular replacement and cardiac biopsy. Histological
examination of the aortic valve revealed myxoid degeneration of valve leaflets,
while cardiac biopsy showed moderate hypertrophaied myocytes and extensive
absence of concentric lamellal bodies of myocytes; a hallmark of Fabry disease.
This paper describes a case report of a male patient with Fabry disease and
severe aortic stenosis who underwent successful aortic valvular replacement
during enzyme replacement therapy
Biography
TBA